Nailfold capillaroscopy in systemic sclerosis: Data from the EULAR scleroderma trials and research (EUSTAR) database

Microvascular Research

Volumn 89, Issue , 2013, Pages 122-128

  Ingegnoli, Francesca ^a   Ardoino, Ilaria ^a   Boracchi, Patrizia ^a   Cutolo, Maurizio ^b   Airò, Paolo ^c   Ananieva, Lidia P ^d   Ancuta, Codrina ^e   Andrade, Luis Eduardo ^f   Becvar, Radim ^g   Benenati, Alessia ^h   Caramaschi, Paola ⁱ   Carreira, Patricia E ^j   Cuomo, Giovanna ^k   Damjanov, Nemanja ^l   Distler, Oliver ^m   Foti, Rosario ^h   Guiducci, Serena ⁿ   Hachulla, Eric ^o   Highton, John ^p   Kayser, Cristiane ^f   Lubatti, Chiara ^a   Cerinic, Marco Matucci ⁿ   Meier, Florian ^q   Meroni, Pier Luigi ^a   Mihai, Carmen Marina ^r   Morgiel, Ewa ^s   Müller Ladner, Ulf ^q   Loyo, Esthela ^t   Ortiz, Vera ^u   Riccieri, Valeria ^v   Scheja, Agneta ^w   Skacelova, Simona ^g   Smith, Vanessa ^x   Stamenkovic, Bojana ^y   Stebbings, Simon ^p   Stoica, Viktor ^r   Sulli, Alberto ^b   Szechinski, Jacek ^s   Tyndall, Alan ^z   Valentini, Gabriele ^k   Walker, Ulrich ^z   Zeni, Silvana ^a   Zlatanovic, Maja ^l   more..

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c SPEDALI CIVILI   (Italy)

^d V A NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY   (Russian Federation)

^e Rheumatology Department   (Romania)

^f FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^g CHARLES UNIVERSITY   (Czech Republic)

^h UNIVERSITY OF CATANIA   (Italy)

ⁱ UNIVERSITY OF VERONA   (Italy)

^j Servicio de Reumatología Hospital 1De Córdoba   (Spain)

^k Dipartimento Medicina Clinica e Sperimentale F MagrassiII Policlinico UO Reumatologia   (Italy)

^l INSTITUTE OF RHEUMATOLOGY   (Serbia)

^m UNIVERSITY HOSPITAL ZURICH   (Switzerland)

ⁿ UNIVERSITY OF FLORENCE   (Italy)

^o LILLE UNIVERSITY HOSPITAL   (France)

^p UNIVERSITY OF OTAGO   (New Zealand)

^q KERCKHOFF HEART CENTER   (Germany)

^r Department of Internal Medicine and Rheumatology ClinicIon Cantacuzino Clinical Hospital Bucharest ^*  (Romania)

^s WROCLAW MEDICAL UNIVERSITY   (Poland)

^t Reumatologia e Inmunologia Clinica   (Dominican Republic)

^u General Hospital of Granollers   (Spain)

^v SAPIENZA UNIVERSITY OF ROME   (Italy)

^w LUND UNIVERSITY HOSPITAL   (Sweden)

^x GHENT UNIVERSITY   (Belgium)

^y Institute for Prevention   (Serbia)

^z Felix Platter Spital   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; SCL 70 ANTIBODY;

ADULT; ARTICLE; CAPILLAROSCOPY; CLINICAL FEATURE; CLUSTER ANALYSIS; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FINGER ULCER; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; JOINT CONTRACTURE; KIDNEY DISEASE; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY (TOPIC); MUSCLE WEAKNESS; PATIENT MONITORING; PHENOTYPE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; REFERENCE DATABASE; SCLERODERMA; SKIN DISEASE; SYNOVITIS; SYSTEMIC SCLEROSIS;

ADULT; AGED; CAPILLARIES; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DISEASE PROGRESSION; FEMALE; HUMANS; INTERNATIONAL COOPERATION; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; PHENOTYPE; QUESTIONNAIRES; SCLERODERMA, SYSTEMIC;

EID: 84883145825     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2013.06.003     Document Type: Article

References (45)

1. Anders H.J., et al. Differentiation between primary and secondary Raynaud's phenomenon: a prospective study comparing nailfold capillaroscopy using an ophthalmoscope or stereomicroscope. Ann. Rheum. Dis. 2001, 60:407-409.
2. Avouac J., et al. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann. Rheum. Dis. 2011, 70:476-481.
3. Baron M., et al. Office capillaroscopy in systemic sclerosis. Clin. Rheumatol. 2007, 26:1268-1274.
4. Beltran E., et al. Assessment of nailfold capillaroscopy by ×30 digital epiluminescence (dermoscopy) in patients with Raynaud phenomenon. Br. J. Dermatol. 2007, 156:892-898.
5. Bredemeier M., et al. Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J. Rheumatol. 2004, 31:286-294.
6. Brown G.E., O'Leary P.A. Skin capillaries in scleroderma. Arch. Intern. Med. 1925, 36:73-88.
7. Bukhari M., et al. Increased nailfold capillary dimensions in primary Raynaud's phenomenon and systemic sclerosis. Br. J. Rheumatol. 1996, 35:1127-1131.
8. Bukhari M., et al. Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy. Rheumatology (Oxford) 2000, 39:506-512.
9. Caramaschi P., et al. Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatology (Oxford) 2007, 46:1566-1569.
10. Chen Z.Y., et al. Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am. J. Med. 1984, 77:812-822.
11. Cutolo M., et al. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J. Rheumatol. 2000, 27:155-160.
12. Cutolo M., et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford) 2004, 43:719-726.
13. Cutolo M., et al. Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat. Rev. Rheumatol. 2010, 6:578-587.
14. Cutolo M., et al. Training in capillaroscopy: a growing interest. J. Rheumatol. 2012, 39:1113-1116.
15. De Angelis R., et al. A growing need for capillaroscopy in rheumatology. Arthritis Rheum. 2009, 61:405-410.
16. Geyer M., Muller-Ladner U. The pathogenesis of systemic sclerosis revisited. Clin. Rev. Allergy Immunol. 2011, 40:92-103.
17. Greenacre M.J. Correspondence Analysis in Practice 1993, 32-37. Academic, London.
18. Hennig C. Cluster Wise Assessment of Cluster Stability Cluster Wise Assessment of Cluster Stability 2007, 52:258-271.
19. Herrick A.L. The pathogenesis, diagnosis and treatment of Raynaud phenomenon. Nat. Rev. Rheumatol. 2012, 8:469-479.
20. Herrick A.L., Cutolo M. Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis. Arthritis Rheum. 2010, 62:2595-2604.
21. Herrick A.L., et al. Nail-fold capillary abnormalities are associated with anti-centromere antibody and severity of digital ischaemia. Rheumatology (Oxford) 2010, 49:1776-1782.
22. Hofstee H.M., et al. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis. Ann. Rheum. Dis. 2009, 68:191-195.
23. Hudson M., et al. Reliability of widefield capillary microscopy to measure nailfold capillary density in systemic sclerosis. Clin. Exp. Rheumatol. 2010, 28:S36-S41.
24. Ingegnoli F., et al. Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (prognostic index for nailfold capillaroscopic examination). Arthritis Rheum. 2008, 58:2174-2182.
25. Ingegnoli F., et al. Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: role of autoantibodies and nail-fold capillaroscopy. Rheumatology (Oxford) 2010, 49:797-805.
26. Kuwana M., et al. Defective vasculogenesis in systemic sclerosis. Lancet 2004, 364:603-610.
27. Lovy M., et al. Relationship between nailfold capillary abnormalities and organ involvement in systemic sclerosis. Arthritis Rheum. 1985, 28:496-501.
28. Maricq H.R., LeRoy E.C. Patterns of finger capillary abnormalities in connective tissue disease by "wide-field" microscopy. Arthritis Rheum. 1973, 16:619-628.
29. Maricq H.R., et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum. 1980, 23:183-189.
30. Maricq H.R., et al. Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin. Exp. Rheumatol. 1983, 1:195-205.
31. Medsger T.A., Steen V.D. Systemic sclerosis. Systemic Sclerosis 1996, 51-79. Lippincott Williams & Wilkins, Philadelphia. P.J. Clements, D.E. Furst (Eds.).
32. Medsger T.A., et al. Assessment of disease severity and prognosis. Clin. Exp. Rheumatol. 2003, 21:S42-S46.
33. Nagy Z., Czirjak L. Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud's disease. J. Eur. Acad. Dermatol. Venereol. 2004, 18:62-68.
34. R Development Core Team R: A language and environment for statistical computing 2006, R-Foundation for Statistical Computing, Vienna, Austria.
35. Schneeberger D., et al. Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database. Rheumatology (Oxford) 2013, 52:560-567.
36. Smith V., et al. Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? A pilot study. Ann. Rheum. Dis. 2012, 71:1636-1639.
37. Sulli A., et al. Timing of transition between capillaroscopic patterns in systemic sclerosis. Arthritis Rheum. 2012, 64:821-825.
38. Tyndall A., et al. Systemic sclerosis in Europe: first report from the EULAR Scleroderma Trials and Research (EUSTAR) group database. Ann. Rheum. Dis. 2005, 64:1107.
39. Valentini G., et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann. Rheum. Dis. 2001, 60:592-598.
40. Valentini G., et al. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann. Rheum. Dis. 2003, 62:901-903.
41. Vayssairat M., et al. Nailfold capillary microscopy as a diagnostic tool and in followup examination. Arthritis Rheum. 1982, 25:597-598.
42. Walker U.A., et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann. Rheum. Dis. 2007, 66:754-763.
43. Wildt M., et al. Capillary density in patients with systemic sclerosis, as determined by microscopy counts and compared with computer-based analysis. Clin. Exp. Rheumatol. 1999, 17:219-222.
44. Wildt M., et al. Assessment of capillary density in systemic sclerosis with three different capillaroscopic methods. Clin. Exp. Rheumatol. 2012, 30:S50-S54.
45. Zulian F., et al. The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum. 2007, 57:203-212.